Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading
about
Receptor complexes for each of the Class 3 SemaphorinsSelective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cellsSemaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effectControl of cellular motility by neuropilin-mediated physical interactionsA review of the past, present, and future directions of neoplasiaComing of Age in the Life ofFunctional interaction between matrix metalloproteinase-3 and semaphorin-3C during cortical axonal growth and guidanceIdentification of genes differentially expressed in rat alveolar type I cells.Differentially expressed genes in embryonic cardiac tissues of mice lacking Folr1 gene activity.Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cellsHormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.Expression by midbrain dopamine neurons of Sema3A and 3F receptors is associated with chemorepulsion in vitro but a mild in vivo phenotype.Navigating breast cancer: axon guidance molecules as breast cancer tumor suppressors and oncogenes.Caveolin-1 regulates Rac1 activation and rat pulmonary microvascular endothelial hyperpermeability induced by TNF-α.Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.Integration of genotypic and phenotypic screening reveals molecular mediators of melanoma-stromal interaction.Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesionThe semaphorins.Semaphorins in angiogenesis and tumor progression.Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage.Class 3 semaphorin signaling: the end of a dogma.The brain within the tumor: new roles for axon guidance molecules in cancers.Altered gene expression in early postnatal monoamine oxidase A knockout mice.Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.Targeting endothelial and tumor cells with semaphorins.The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluationSemaphorins and their receptors in lung cancer.High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer.The semaphorins: versatile regulators of tumour progression and tumour angiogenesis.Semaphorin signals on the road to cancer invasion and metastasis.Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion.Expression of Semaphorin 3F and Its Receptors in Epithelial Ovarian Cancer, Fallopian Tubes, and Secondary Müllerian Tissues.Neuropilins: a new target for cancer therapy.The emerging role of class-3 semaphorins and their neuropilin receptors in oncology.Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.The role of the semaphorins in cancer.The role of axon guidance factor semaphorin 6B in the invasion and metastasis of gastric cancer.Neuropilin-2 acts as a modulator of Sema3A-dependent glioma cell migration.Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program.
P2860
Q21129485-037E6807-A89B-42DB-A285-4E0643D95B22Q24550871-8538C72F-D1C0-4545-99FB-A504F1029F97Q24562741-784281AA-2EEE-4045-B21B-47405E7865D0Q24564247-150331ED-3C0F-423C-95CD-85242C7704E9Q27027713-134190F0-1404-478D-9FC7-EC3F6724BE92Q28389391-DD78749C-5DD3-4B31-9073-9D73B915D903Q28389985-C3BA9244-043B-4354-93B9-99966B4F2904Q28506945-3B7ED930-2C16-4563-BEDC-B05FFB393D27Q33203897-E8641FD0-AE6B-4256-A845-BAAAECFE7323Q33306610-3E44512B-7471-409E-BE66-699078B86932Q33372124-1F581BC6-2DC4-4C43-AAFE-7C933F3C3D50Q33647661-0471A3FA-47F8-4F21-8C3B-085E91A27F36Q33823772-9049095D-B3F1-486B-AC75-178E40B3EDD6Q33853031-235284D9-A50D-4894-9FDB-4545F1ABA38DQ34576220-FA954B41-2925-4F07-ABA9-1A3B40332FD2Q34637615-DACC1EEB-40BC-4F5C-88D2-24965AD13BD4Q34762113-E0F3CB7F-9713-4404-B27B-8ADB64410EEBQ34768320-49E4120C-AB12-48FB-9120-641CB9AAA013Q35012897-5A9CAECA-76F4-4526-B5AD-9336A57D28C9Q35658200-195BECF0-E038-46A8-9D4C-4056DE6CEF3CQ35866684-3F7B1CD4-5B56-4558-824E-7EE3630F00D3Q36138195-34DA0AFD-D3FC-4D3C-B3CC-8830BC8BF522Q36193422-DA67E50E-75F1-457B-8A06-B9A4FE2A8EA9Q36378850-FF01AEDE-FEE9-4650-9D6F-5F6949E8AEC9Q36808641-BD2BF982-9CDB-42B4-A9F9-B05BB939EB80Q36928030-C2F37243-8B4F-45B0-B6B4-FA85BC69C818Q37027655-2A630088-DB87-4525-8D40-3F330B198DC7Q37072227-42BE0E61-3608-4C82-8008-D3D4382D9F5FQ37077487-310479D3-7658-4441-9454-D26B94460E12Q37200576-C6F78246-4850-4027-A6AA-E4DB59EB230EQ37426239-46DD6E62-5CE6-42AC-BC14-1DB223238E60Q37475741-FD151FBC-4625-447F-9150-3302FA505953Q37484796-365EA0C5-AB24-445F-BA94-2165E83D1B9CQ38161356-80C21405-2B82-4560-9323-1A54672BE040Q38256958-5A7E90EB-5D33-4F8F-A722-045501733651Q38807200-D2EF232A-D417-4302-8E19-F623B45AB306Q38929961-C9157D74-0BD0-4525-A8E9-687FC92CDF64Q39137754-75ECBC4E-82CF-48F6-A791-488D45CB678FQ39783663-956EEF5A-3753-4FB4-B8E8-BFCCA40C56B4Q41491009-46DC181A-CA7F-42D1-80CB-1292B8F60C78
P2860
Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading
description
2003 nî lūn-bûn
@nan
2003 թուականին հրատարակուած գիտական յօդուած
@hyw
2003 թվականին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading
@ast
Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading
@en
Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading
@nl
type
label
Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading
@ast
Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading
@en
Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading
@nl
prefLabel
Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading
@ast
Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading
@en
Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading
@nl
P2093
P2860
P1433
P1476
Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading
@en
P2093
Bruno Constantin
Guy Raymond
Harry A Drabkin
Joëlle Roche
Lydie Rouhaud
Nicolas Bourmeyster
Patrick Nasarre
Thomas Harnois
P2860
P356
10.1016/S1476-5586(03)80020-9
P407
P577
2003-01-01T00:00:00Z